###begin article-title 0
Methylation-Dependent Binding of the Epstein-Barr Virus BZLF1 Protein to Viral Promoters
###end article-title 0
###begin p 1
Conceived and designed the experiments: SJD SCK. Performed the experiments: SJD YX ARR WTS. Analyzed the data: SJD YX ARR WTS SCK. Contributed reagents/materials/analysis tools: YX HG. Wrote the paper: SJD SCK.
###end p 1
###begin p 2
###xml 718 719 718 719 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 717 724 717 724 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">A<bold>C</bold>GCTCA</named-content>
###xml 730 731 730 731 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 734 735 734 735 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 729 736 729 736 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">T<bold>C</bold>GCC<bold>C</bold>G</named-content>
###xml 36 54 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 56 59 <span type="species:ncbi:10376">EBV</span>
###xml 540 543 <span type="species:ncbi:10376">EBV</span>
###xml 845 848 <span type="species:ncbi:10376">EBV</span>
###xml 1310 1313 <span type="species:ncbi:10376">EBV</span>
The switch between latent and lytic Epstein-Barr virus (EBV) infection is mediated by the viral immediate-early (IE) protein, BZLF1 (Z). Z, a homologue of c-jun that binds to AP1-like motifs (ZREs), induces expression of the BRLF1 (R) and BRRF1 (Na) viral proteins, which cooperatively activate transcription of the Z promoter and thereby establish a positive autoregulatory loop. A unique feature of Z is its ability to preferentially bind to, and activate, the methylated form of the BRLF1 promoter (Rp). To date, however, Rp is the only EBV promoter known to be regulated in this unusual manner. We now demonstrate that the promoter driving transcription of the early BRRF1 gene (Nap) has two CpG-containing ZREs (ACGCTCA and TCGCCCG) that are only bound by Z in the methylated state. Both Nap ZREs are highly methylated in cells with latent EBV infection. Z efficiently activates the methylated, but not unmethylated, form of Nap in reporter gene assays, and both ZREs are required. Z serine residue 186, which was previously shown to be required for Z binding to methylated ZREs in Rp, but not for Z binding to the AP1 site, is required for Z binding to methylated Nap ZREs. The Z(S186A) mutant cannot activate methylated Nap in reporter gene assays and does not induce Na expression in cells with latent EBV infection. Molecular modeling studies of Z bound to the methylated Nap ZREs help to explain why methylation is required for Z binding, and the role of the Z Ser186 residue. Methylation-dependent Z binding to critical viral promoters may enhance lytic reactivation in latently infected cells, where the viral genome is heavily methylated. Conversely, since the incoming viral genome is initially unmethylated, methylation-dependent Z activation may also help the virus to establish latency following infection.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRRF1</italic>
###xml 844 849 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRLF1</italic>
###xml 854 859 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRRF1</italic>
###xml 31 49 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 51 54 <span type="species:ncbi:10376">EBV</span>
###xml 87 90 <span type="species:ncbi:10376">EBV</span>
###xml 275 278 <span type="species:ncbi:10376">EBV</span>
###xml 475 478 <span type="species:ncbi:10376">EBV</span>
###xml 566 569 <span type="species:ncbi:10376">EBV</span>
###xml 1032 1035 <span type="species:ncbi:10376">EBV</span>
In cells with long-term latent Epstein-Barr virus (EBV) infection, the majority of the EBV genome becomes highly methylated. Methylation of cytosines plays a critical role in inhibiting the expression of cellular genes. In contrast, our laboratory previously showed that the EBV protein, BZLF1 (Z), which mediates viral reactivation and replication, preferentially binds to, and activates, the methylated form of the viral BRLF1 promoter. To date, however, BRLF1 is the only EBV promoter known to be activated by Z in this unusual manner. Here, we show that another EBV promoter (Nap, driving transcription of the BRRF1 gene) likewise has two methylation-dependent Z binding sites, and that Z only activates the Nap efficiently in the methylated form. Molecular modeling studies suggest why methylation of the Nap enhances Z binding. Since the BRLF1 and BRRF1 genes encode essential viral transcription factors that work cooperatively with Z to induce the lytic form of viral infection, our results indicate that methylation of the EBV genome enhances Z-mediated disruption of viral latency.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Rickinson1">[1]</xref>
###xml 141 144 141 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-zurHausen1">[2]</xref>
###xml 213 216 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Rickinson1">[1]</xref>
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Sixbey1">[3]</xref>
###xml 516 519 516 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Rickinson1">[1]</xref>
###xml 521 524 521 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-KieffE1">[4]</xref>
###xml 525 528 525 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Laichalk1">[7]</xref>
###xml 692 695 692 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Israel1">[8]</xref>
###xml 1088 1091 1088 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Rickinson1">[1]</xref>
###xml 1092 1095 1092 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-KieffE1">[4]</xref>
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 20 23 <span type="species:ncbi:10376">EBV</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 146 149 <span type="species:ncbi:10376">EBV</span>
###xml 260 263 <span type="species:ncbi:10376">EBV</span>
###xml 980 983 <span type="species:ncbi:10376">EBV</span>
###xml 1138 1141 <span type="species:ncbi:10376">EBV</span>
Epstein-Barr virus (EBV) is a human gammaherpesvirus associated with B-cell lymphomas, nasopharyngeal carcinoma (NPC) and gastric cancer [1],[2]. EBV primarily infects two cell types, epithelial cells and B cells [1],[3]. As is the case for all herpesviruses, EBV can infect cells in either latent, or lytic, forms. Lytic replication, which is required for horizontal spread of the virus from cell to cell, and from host to host, occurs in epithelial cells and following differentiation of B cells into plasma cells [1], [4]-[7]. Lytic replication is mediated by the virally encoded DNA polymerase using the oriLyt replication origin, and results in the release of infectious viral particles [8]. In contrast, during latent viral infection (which normally occurs in memory B cells), only a subset of viral genes is expressed, the genome is replicated once per cell cycle using the cellular DNA polymerase and the oriP replication origin, and progeny virus is not released. Latent EBV infection allows the virus to persist for the life of the host and avoid detection by the immune system [1],[4]. Thus, both the latent and lytic forms of EBV infection are essential for viral pathogenesis.
###end p 6
###begin p 7
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-KieffE1">[4]</xref>
###xml 120 123 120 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Takada1">[6]</xref>
###xml 125 128 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Countryman1">[9]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-ChevallierGreco1">[11]</xref>
###xml 240 243 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Israel1">[8]</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Chang1">[12]</xref>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Flemington2">[15]</xref>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Adamson1">[16]</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Gruffat1">[17]</xref>
###xml 786 791 786 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRRF1</italic>
###xml 915 920 915 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BZLF1</italic>
###xml 935 939 935 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-SegouffinCariou1">[18]</xref>
###xml 940 944 940 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Hong1">[19]</xref>
###xml 1106 1110 1106 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Gonzalez1">[20]</xref>
###xml 1111 1115 1111 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Lee1">[21]</xref>
###xml 984 987 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 1060 1063 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
The switch from latent to lytic infection is mediated by the immediate-early (IE) proteins BZLF1 (Z) and BRLF1 (R) [4], [6], [9]-[11]. Z and R are transcription factors which activate one another's promoters, as well as their own promoters [8]. In combination, Z and R induce expression of all early lytic viral proteins, allowing the virus to replicate. Z is a bZip protein homologous to c-jun and c-fos that binds to the consensus AP1 motif as well as atypical AP1-like motifs known as Z-responsive elements (ZREs) [12]-[15]. R activates some early promoters through a direct binding mechanism, but activates the BZLF1 promoter indirectly through effects on cellular transcription factors (c-jun and ATF-2) binding to a CRE motif [16],[17]. An early viral protein, Na (encoded by the BRRF1 gene located on the opposite strand of the first R intron), induces c-jun phosphorylation and cooperates with R to enhance BZLF1 transcription [18],[19]. The Na homologues in KSHV (ORF49) and MHV-68 (ORF49) likewise collaborate with their R homologues (KSHV ORF50 and MHV-68 Rta) to activate lytic viral promoters [20],[21].
###end p 7
###begin p 8
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Minarovits1">[24]</xref>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bird1">[25]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Lewis1">[33]</xref>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRLF1</italic>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende2">[34]</xref>
###xml 905 909 905 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
###xml 910 914 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende2">[34]</xref>
###xml 1029 1033 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende2">[34]</xref>
###xml 1133 1137 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Petosa1">[35]</xref>
###xml 4 7 <span type="species:ncbi:10376">EBV</span>
###xml 116 119 <span type="species:ncbi:10376">EBV</span>
###xml 493 496 <span type="species:ncbi:10376">EBV</span>
The EBV genome is not methylated in virions. However, in cells with long-term latent infection, the majority of the EBV genome becomes highly methylated [22]-[24]. DNA methylation, which plays a critical role in modulating the expression of both cellular and viral genes, induces transcriptional repression by multiple different mechanisms, including prevention of transcription factor binding to DNA and the recruitment of HDAC complexes [25]-[33]. Surprisingly, while DNA methylation of the EBV IE BRLF1 promoter (Rp) inhibits its activation by cellular transcription factors, it enhances the ability of Z to activate the Rp [34]. This unusual effect of Rp methylation on Z activation is due to the enhanced ability of Z to bind to the methylated, versus unmethylated, forms of two atypical CpG-containing Rp ZRE sites (Rp ZRE2 and Rp ZRE3), and requires serine residue 186 in the basic DNA domain of Z [22],[34]. The Rp also has one CpG-free ZRE, and can be activated by Z in the unmethylated form, albeit it less efficiently [34]. Although the crystal structure of Z bound to the consensus AP1 site has been previously published [35], the structure of Z bound to methylated site has not been published.
###end p 8
###begin p 9
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Adamson2">[36]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Francis1">[37]</xref>
###xml 147 150 <span type="species:ncbi:10376">EBV</span>
Z is the only transcription factor known to preferentially activate the methylated form of a target promoter. To date, however, the Rp is the only EBV promoter shown to have CpG-containing ZREs. A variety of studies have suggested that Rp activation is the essential first step required for Z disruption of viral latency, and that both Z and R expression are required for induction of most early lytic genes in the context of the intact viral genome [36],[37]. The apparently unique effect of methylation on Z binding to the Rp, but not other lytic viral promoters, may ensure that at the earliest stages of viral reactivation limiting amounts of Z are initially bound to the Rp rather than other lytic viral promoters.
###end p 9
###begin p 10
###xml 446 454 446 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 334 337 <span type="species:ncbi:10376">EBV</span>
###xml 886 889 <span type="species:ncbi:10376">EBV</span>
In this paper, we demonstrate that the Na early lytic viral promoter (Nap) has two CpG-containing ZREs that can only be bound by Z in the methylated form. Furthermore, we show that Nap methylation is required for efficient Z activation of the Nap. We also demonstrate that the CpG motifs in the Nap ZREs are usually methylated on the EBV genome during latent infection, and that a Z mutant, Z(S186A), which cannot bind to the methylated Nap ZREs in vitro is unable to activate Na expression in latently infected cells. Our molecular modeling of Z bound to the newly discovered methylated ZREs in the Nap, versus the consensus AP1 site, helps to explain why methylation is required for Z binding to some ZREs, and the role that the Z Ser186 residue plays in this binding. The apparently unique ability of Z to activate the methylated forms of the R and Na promoters, but not other lytic EBV promoters, may be a mechanism by which the virus ensures that R and Na are the first genes activated during Z-mediated reactivation in latently infected cells. Conversely, the inability of Z to activate R and Na transcription efficiently from the incoming unmethylated viral genome may serve to promote viral latency.
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
Cell lines
###end title 12
###begin p 13
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Feederle1">[38]</xref>
###xml 578 582 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Park1">[39]</xref>
###xml 807 811 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Boukamp1">[40]</xref>
###xml 1037 1041 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Stewart1">[41]</xref>
###xml 221 227 <span type="species:ncbi:9913">bovine</span>
###xml 319 322 <span type="species:ncbi:10376">EBV</span>
###xml 363 366 <span type="species:ncbi:10376">EBV</span>
###xml 443 446 <span type="species:ncbi:10376">EBV</span>
###xml 456 461 <span type="species:ncbi:9606">human</span>
###xml 537 540 <span type="species:ncbi:10376">EBV</span>
###xml 778 783 <span type="species:ncbi:9606">human</span>
###xml 889 892 <span type="species:ncbi:10376">EBV</span>
###xml 927 932 <span type="species:ncbi:9606">human</span>
###xml 973 976 <span type="species:ncbi:10376">EBV</span>
###xml 1050 1053 <span type="species:ncbi:10376">EBV</span>
293 cells infected with the Z-KO virus (293 Z-KO) were a gift from Henri-Jacques Delecluse and have been described previously [38]. 293 Z-KO were maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS), 1% penicillin-streptomycin, and hygromycin B (100 microg/mL; Roche). DG75, an EBV-negative B-cell lymphoma line, Raji, an EBV-positive Burkitt lymphoma cell line, HONE-1 (a gift from Ronald Glaser), an EBV-negative human nasopharyngeal carcinoma (NPC) cell line, and SNU-719, a naturally derived EBV-infected gastric carcinoma cell line [39], were maintained in RPMI 1640 medium with 10% FBS and 1% penicillin-streptomycin. HeLa, a cervical adenocarcinoma line, were maintained in DMEM with 10% FBS and penicillin-streptomycin. HaCaT, a human keratinocyte cell line [40], were maintained in F media with 10% FBS and penicillin-streptomycin. HONE-1/EBV (a gift from Lawrence Young) is a human NPC cell line that stably maintains the EBV (Akata strain) genome under G418 selection in a latent form [41]. HONE-1/EBV cells were maintained in RPMI medium 1640 with 10% FBS, penicillin-streptomycin and G418 (400 microg/mL; Sigma).
###end p 13
###begin title 14
Plasmids
###end title 14
###begin p 15
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRRF1</italic>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRLF1</italic>
###xml 1183 1191 1183 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1364 1372 1364 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 698 701 <span type="species:ncbi:10376">EBV</span>
###xml 995 999 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1481 1485 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Plasmid DNA was purified through columns as described by the manufacturer (QIAGEN). Nap-LUC contains the Nap sequences from +76 to -209 (relative to the BRRF1 transcription start site) inserted upstream of the luciferase gene in the pGL3-basic vector (Promega). Mutations to the Nap-LUC construct were created using the QuikChange site-directed mutagenesis kit (Stratagene). Rp-LUC contains the Rp sequences from +37 to -1069 (relative to the BRLF1 transcription start site) inserted upstream of the luciferase gene in the pGL3-basic vector (Promega). BHLF1p-LUC was constructed by PCR amplifying the divergent BHLF1 and BHRF1 promoter sequences (from 52781 to 53797) within the oriLyt region from EBV B95.8 genomic DNA and inserting it in the pBSLUCCAT construct; this plasmid contains the firefly luciferase gene under the transcriptional control of the BHLF1 promoter and CAT gene under the control of the BHRF1 promoter. The Z expression vector (pSG5-Z) contains genomic Z downstream of the SV40 promoter (a gift from S. Diane Hayward) in the pSG5 vector (Stratagene). The Z cDNA (a gift from Paul Farrell) was cloned into the pSG5 vector to create pSG5-ZcDNA, which was used to in vitro translate the Z protein. Z(S186A) and Z(C189S) mutations in the pSG5-ZcDNA vector were constructed using the QuikChange site-directed mutagenesis kit (Stratagene) to allow in vitro translation of the mutant proteins. The R expression plasmid contains genomic R sequences downstream of the SV40 promoter in the pSG5 vector (a gift from S. Diane Hayward).
###end p 15
###begin title 16
DNA transfection
###end title 16
###begin p 17
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Transfections of 293 Z-KO and HONE-1 cells were performed by use of Lipofectamine 2000 (Invitrogen). Cells (8x105) were seeded the day prior to transfection in 2 mL of medium in a six-well plate. Transfections were performed according to the manufacturer's instructions, except that the reagent:DNA ratio was 3 microL:1.5 microg. Transfections of HeLa and HaCaT cells for reporter assays were performed by use of Fugene 6 (Roche) according to the manufacturer's instructions. DG75 cells were electroporated using 10 microg DNA with the Bio-Rad Gene Pulser Xcell device, using 250 V, 975 microF, infinity Omega, 4 mm cuvettes.
###end p 17
###begin title 18
Immunoblotting
###end title 18
###begin p 19
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende3">[42]</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-SegouffinCariou1">[18]</xref>
###xml 593 599 <span type="species:ncbi:9986">rabbit</span>
###xml 682 693 <span type="species:ncbi:3704">horseradish</span>
Immunoblotting was performed as described previously [22],[42]. Briefly, cells were lysed in SUMO lysis buffer; equivalent amounts of protein were then separated in sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis gels (SDS-PAGE) and transferred to membranes. Membranes blocked in 5% milk then incubated at room temperature for 1 h with the appropriate primary antibodies diluted in 5% milk in 1x PBS and 0.1% Tween 20 (PBS-T). Primary antibody dilutions were as follows: 1:250 anti-BRLF1 (Argene), 1:250 anti-ZEBRA (Santa Cruz, sc-53904), 1:250 anti-EA-D (Vector), 1:300 anti-Na rabbit antibody [18] and 1:5,000 anti-beta-actin (Sigma). After washing, the appropriate horseradish peroxidase conjugated secondary antibodies (Pierce) were used at a dilution of 1:7,000 in 5% milk in 1x PBS-T for 1 h at room temperature and washed. Bound antibodies were visualized by use of enhanced chemiluminescent reagent (Pierce) according to the manufacturer's instructions.
###end p 19
###begin title 20
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro DNA methylation
###end title 20
###begin p 21
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 91 113 91 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SssI methyltransferase</italic>
###xml 282 285 282 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hpa</italic>
In vitro DNA methylation of the luciferase constructs was accomplished with CpG methylase (SssI methyltransferase; New England Biolabs), by following the procedure recommended by the manufacturer. Completion of DNA methylation was confirmed by digestion with the restriction enzyme HpaII (New England Biolabs), which cleaves its recognition sequence only if the DNA is not methylated at the cytosine residue within the CpG motif.
###end p 21
###begin title 22
Luciferase assays
###end title 22
###begin p 23
Luciferase assays were performed 48 h after transfection by using extracts prepared by freeze-thawing the cell pellet in reporter lysis buffer according to the instructions of the manufacturer (Promega). Luciferase activity was assayed using the luciferase reporter assay system (Promega) as suggested by the manufacturer.
###end p 23
###begin title 24
Chromatin immunoprecipitation (ChIP) assay
###end title 24
###begin p 25
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 529 566 517 554 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCC TGT TGT TTC GGA GAA TGG CCC-3&#8242;</named-content>
###xml 571 611 559 599 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGA AGA CTT TCT GAG GCT AAC TCC TG-3&#8242;</named-content>
###xml 622 655 610 643 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCG TCT GGA CGA CGC TGG CGA-3&#8242;</named-content>
###xml 660 696 648 684 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTC CAG GTA CCA CCC ACC TGG TG-3&#8242;</named-content>
###xml 709 740 697 728 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCG TAG AAG TAG GCC TGC T-3&#8242;</named-content>
###xml 745 773 733 761 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGG AAG CCC TCT GGA CTT C</named-content>
###xml 288 292 <span type="species:ncbi:9925">goat</span>
###xml 352 356 <span type="species:ncbi:9925">goat</span>
293 Z-KO cells (3x107 cells per condition) were transfected with a control vector or vector encoding Z and harvested after 20 h for ChIP assays using a modified Upstate ChIP protocol (Millipore, Billerica, MA). Chromatin was sonicated to approximately400 bp. Antibodies used were control goat polyclonal immunoglobulin G (IgG)(Santa Cruz, sc-2028) and goat anti-ZEBRA (vE-20) (Santa Cruz, sc-17503). Input (total) DNA was obtained from samples not incubated with antibody. ChIP DNA was analyzed using the following primers: Nap (5'-CCC TGT TGT TTC GGA GAA TGG CCC-3' and 5'-GGA AGA CTT TCT GAG GCT AAC TCC TG-3'); oriLyt (5'-GCG TCT GGA CGA CGC TGG CGA-3' and 5'-CTC CAG GTA CCA CCC ACC TGG TG-3') and BALF5 (5'-GCG TAG AAG TAG GCC TGC T-3' and 5'-CGG AAG CCC TCT GGA CTT C).
###end p 25
###begin title 26
Probes for electrophoretic mobility shift assay (EMSA)
###end title 26
###begin p 27
###xml 245 247 245 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRRF1</italic>
###xml 799 807 799 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 814 820 814 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. Sss</italic>
###xml 1015 1020 1015 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMRF1</italic>
###xml 1276 1278 1276 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1451 1452 1451 1452 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1456 1457 1456 1457 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1449 1458 1449 1458 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T <bold>C</bold>GC C<bold>C</bold>G</underline>
###xml 1440 1469 1440 1469 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAT TC<underline>T <bold>C</bold>GC C<bold>C</bold>G</underline> TGG GCC-3&#8242;</named-content>
###xml 1485 1486 1485 1486 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 1485 1486 1485 1486 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>C</underline></bold>
###xml 1490 1491 1490 1491 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1486 1494 1486 1494 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG G<bold>C</bold>G A</underline>
###xml 1474 1503 1474 1503 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGC CCA <bold><underline>C</underline></bold><underline>GG G<bold>C</bold>G A</underline>GA ATG-3&#8242;</named-content>
###xml 1539 1540 1539 1540 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1533 1542 1533 1542 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T GAG <bold>C</bold>GT</underline>
###xml 1528 1552 1528 1552 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GT<underline>T GAG <bold>C</bold>GT</underline> GGC CA-3&#8242;</named-content>
###xml 1568 1569 1568 1569 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1566 1575 1566 1575 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A <bold>C</bold>GC TCA</underline>
###xml 1557 1581 1557 1581 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGG CC<underline>A <bold>C</bold>GC TCA</underline> AC-3&#8242;</named-content>
###xml 1608 1617 1608 1617 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGA GTC A</underline>
###xml 1593 1630 1593 1630 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAT GAC CTT <underline>TGA GTC A</underline>GG TGG CTA-3&#8242;</named-content>
###xml 1648 1657 1648 1657 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T GAC TCA</underline>
###xml 1635 1672 1635 1672 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAG CCA CC<underline>T GAC TCA</underline> AGG GTC ATC-3&#8242;</named-content>
###xml 1695 1696 1695 1696 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1698 1699 1698 1699 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1694 1703 1694 1703 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T<bold>C</bold> G<bold>C</bold>G AA</underline>
###xml 1682 1711 1682 1711 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAT AGC A<underline>T<bold>C</bold> G<bold>C</bold>G AA</underline>T TTT-3&#8242;</named-content>
###xml 1727 1728 1727 1728 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1729 1730 1729 1730 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1716 1745 1716 1745 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAA ATT <bold>C</bold>G<bold>C</bold> GAT GCT ATA-3&#8242;</named-content>
###xml 1766 1767 1766 1767 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1764 1773 1764 1773 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T <bold>C</bold>GC TCA</underline>
###xml 1755 1787 1755 1787 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAA AA<underline>T <bold>C</bold>GC TCA</underline> TAA GCT TA-3&#8242;</named-content>
###xml 1811 1812 1811 1812 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1805 1814 1805 1814 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T GAG <bold>C</bold>GA</underline>
###xml 1792 1824 1792 1824 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAA GCT TA<underline>T GAG <bold>C</bold>GA</underline> TTT TA-3&#8242;</named-content>
###xml 492 495 <span type="species:ncbi:10376">EBV</span>
###xml 1011 1014 <span type="species:ncbi:10376">EBV</span>
A series of probes spanning the BRLF1 promoter sequences (from -1 to -270) or the BRRF1 (Nap) promoter sequences from -280 to -470, -108 to -301, and +77 to -128 (relative to the BRRF1 mRNA start site) were created by PCR amplification and were 32P end-labeled with T4 Polynucleotide Kinase (New England Biolabs) in accordance with the manufacturer's instructions. In addition, a series of oligonucleotide probes were synthesized as shown below (with positions of the oligonucleotides in the EBV genome relative to the BRRF1 start site shown in parentheses). ZRE sequences are underlined. The oligonucleotides were synthesized without methylated cytosines at the CpG motif(s) within potential ZRE sites (MWG Biotech). The double-stranded oligonucleotides were either left unmethylated or methylated in vitro using M. SssI CpG methylase (New England Biolabs), then purified by phenol-chloroform extraction and ethanol precipitation. Oligonucleotides containing Rp ZRE2, Rp ZRE3 and a consensus AP1 site from the EBV BMRF1 promoter were also synthesized. Additionally, a series of oligonucleotides with or without methylated cytosines at the CpG motif(s) in potential Nap ZREs were synthetically synthesized (Sigma). Double-stranded oligonucleotide probes were end labeled with 32P using T4 Polynucleotide Kinase. Oligonucleotide sequences are as follows (with the cytosine of the CpG motif is shown in boldface type): Nap ZRE-1 (-41 to -58) 5'-CAT TCT CGC CCG TGG GCC-3' and 5'-GGC CCA CGG GCG AGA ATG-3'; Nap ZRE-2 (-70 to -83) 5'-GTT GAG CGT GGC CA-3' and 5'-TGG CCA CGC TCA AC-3', BMRF1 AP1 5'-GAT GAC CTT TGA GTC AGG TGG CTA-3' and 5'-TAG CCA CCT GAC TCA AGG GTC ATC-3', Rp ZRE3 5'-TAT AGC ATC GCG AAT TTT-3' and 5'-AAA ATT CGC GAT GCT ATA-3', Rp ZRE2 5'-TAA AAT CGC TCA TAA GCT TA-3' and 5'-TAA GCT TAT GAG CGA TTT TA-3'.
###end p 27
###begin title 28
EMSAs
###end title 28
###begin p 29
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 408 416 400 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
In vitro translated wild-type and mutant Z proteins were generated using TNT T7 Quick Coupled Transcription/Translation System (Promega) in accordance with the manufacturer's instructions. Z binding reactions were carried out in a buffer consisting of 100 mM KCl, 20 mM HEPES (pH 7.3), 10% glycerol, 0.2 mM EDTA and 4 mM dithiothreitol (DTT) with 2 microg of poly(dI/dC)/poly(dI/dC) (Pharmacia). 2 microL of in vitro translated protein were added to each reaction and incubated at 4degreesC for 10 min before adding labeled probe (20,000 c.p.m.). The reactions were incubated for 30 min at 4degreesC before being loaded onto a 4% polyacrylamide gel and separated in 0.5x Tris-borate-EDTA buffer at 35 mA at room temperature. Image quantifications were performed using ImageQuant software.
###end p 29
###begin title 30
###xml 65 68 <span type="species:ncbi:10376">EBV</span>
Determining the methylation status of Nap in the viral genome of EBV-infected cell lines
###end title 30
###begin p 31
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRRF1</italic>
###xml 323 355 323 355 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTGTTTATGGTGGTAGGAATTATTAT-3&#8242;</named-content>
###xml 360 393 360 393 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAACTAAACTCTCTAATCTCTAACTAC-3&#8242;</named-content>
###xml 45 48 <span type="species:ncbi:10376">EBV</span>
###xml 295 298 <span type="species:ncbi:10376">EBV</span>
Total genomic DNA was isolated from cultured EBV-positive cells using the DNeasy tissue kit (QIAGEN). Bisulfite modification of genomic DNA was performed using the EpiTect bisulfite kit (QIAGEN) in accordance with the manufacturer's instructions. The modified DNA was amplified by PCR using the EBV BRRF1 promoter primers: 5'-GTGTTTATGGTGGTAGGAATTATTAT-3' and 5'-CAACTAAACTCTCTAATCTCTAACTAC-3'. Thermal cycler conditions for the PCR were as follows: 1 cycle at 95degreesC for 10 m followed by 35 cycles of 95degreesC for 30 s, 52degreesC for 40 s, 70degreesC for 40 s, and a final extension of 72degreesC for 7 m. PCR products were agarose gel purified with a QIAGEN gel extraction kit and then cloned into the pT7Blue Perfectly Blunt Cloning Kit (Novagen). For each cell line, 5 to 10 clones were sequenced to determine the methylation status of the Na promoter.
###end p 31
###begin title 32
Molecular modeling
###end title 32
###begin p 33
Structures of Z bound to four different ZREs were modeled based on the crystal structure of Z (S186A, C189S) bound to the AP1 site (PDB code: 2c9l) using the Sybyl program. Residues 186 and 189 of Z were changed back to wild type sequence; and the AP1 sequence was replaced by the sequence of each ZRE followed by addition of a methyl group to the C5 position of each CpG. Modeling was finished by several rounds of manual model building and energy minimization.
###end p 33
###begin title 34
Accession numbers
###end title 34
###begin p 35
###xml 0 3 <span type="species:ncbi:10376">EBV</span>
EBV genome, type 1 NC_007605; Z (BZLF1) Swiss-Prot P03206.
###end p 35
###begin title 36
Results
###end title 36
###begin title 37
Z preferentially binds to the methylated form of the Na promoter (Nap)
###end title 37
###begin p 38
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-SegouffinCariou1">[18]</xref>
###xml 678 685 678 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g001">Fig. 1A</xref>
###xml 737 744 737 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 511 514 <span type="species:ncbi:10376">EBV</span>
Regulation of the Nap by viral and cellular factors has not been well studied. Although the Nap was previously reported to be activated by Z, but not R, in reporter gene assays, specific ZRE sites required for Z activation of the Nap were not defined [18]. Furthermore, although the Nap has a number of potential CpG-containing ZRE motifs, the effect of methylation on Z binding to the Nap has not previously been examined. To determine if Z binds to the Nap in the context of the intact viral genome, latently EBV infected 293 cells were transfected with a Z expression vector or a control vector, and ChIP assays were performed 20 hours later to detect Z binding. As shown in Fig. 1A, the ChIP assays confirmed that Z binds to the Nap in vivo.
###end p 38
###begin title 39
Z binds to the Na promoter, and binding is enhanced by Nap methylation.
###end title 39
###begin p 40
###xml 448 456 448 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 481 483 481 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 666 671 666 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRRF1</italic>
###xml 22 25 <span type="species:ncbi:10376">EBV</span>
###xml 229 233 <span type="species:ncbi:9925">goat</span>
###xml 325 328 <span type="species:ncbi:10376">EBV</span>
###xml 359 362 <span type="species:ncbi:10376">EBV</span>
###xml 394 397 <span type="species:ncbi:10376">EBV</span>
(A) Latently infected EBV+ 293 Z-KO cells were transfected with a BZLF1 expression vector (+) or an empty vector control (-). Chromatin immunoprecipitation assay was performed 20 hours after transfection using anti-Z and control goat IgG antibodies as indicated to examine Z binding to the Na promoter (Nap), ZREs within the EBV oriLyt (positive control) and EBV sequences in the 3' end of the EBV BALF5 gene (negative control). (B) The ability of in vitro translated Z to bind to 32P end-labeled probes (in either the methylated, or unmethylated forms) containing the BRRF1 promoter (Nap) sequences from -280 to -470, -108 to -301, and +77 to -128 (relative to the BRRF1 mRNA start site) was examined by EMSA. A probe containing the BRLF1 promoter (Rp) sequences from -1 to -270 (in the methylated form) served as a positive control.
###end p 40
###begin p 41
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRRF1</italic>
###xml 473 480 473 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g001">Fig. 1B</xref>
To locate potential ZRE sites in the Nap, we performed EMSAs using in vitro translated Z and a series of unmethylated or methylated probes spanning the Nap sequences between -470 and +77. The methylated form of a probe containing BRLF1 promoter (Rp) sequences (from -1 to -270) served as a positive control for Z binding. The only Nap probe that had detectable Z binding contained Nap promoter sequences from -128 and +77 (relative to the BRRF1 transcriptional start site)(Fig. 1B). Furthermore, Z bound to the methylated form of this Nap probe more efficiently than to the unmethylated form. These results suggested that Z may preferentially activate the methylated form of Nap.
###end p 41
###begin title 42
Methylation of the Nap inhibits its constitutive activity
###end title 42
###begin p 43
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende2">[34]</xref>
###xml 672 679 672 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g002">Fig. 2A</xref>
###xml 173 176 <span type="species:ncbi:10376">EBV</span>
###xml 563 566 <span type="species:ncbi:10376">EBV</span>
###xml 631 634 <span type="species:ncbi:10376">EBV</span>
###xml 930 933 <span type="species:ncbi:10376">EBV</span>
Although promoter DNA methylation generally inhibits the ability of cellular transcription factors to activate gene expression, we previously showed that methylation of the EBV Rp enhances its ability to be activated by Z in co-transfection reporter gene assays [22],[34]. To examine how Nap methylation affects its ability to be activated by cellular and viral factors, we inserted the Nap sequence upstream of the luciferase gene to create the Nap-LUC construct. In the absence of promoter DNA methylation, Nap had strong constitutive activity in two different EBV-negative epithelial cell lines (HaCaT and HONE-1) as well as an EBV-negative B cell lymphoma line (DG75)(Fig. 2A). In comparison to the Nap, the constitutive activity of an Rp-driven luciferase construct (Rp-LUC) was much weaker in all three cell lines. These results suggest that the unmethylated form of the Nap has strong constitutive activity in a variety of EBV-negative cell lines.
###end p 43
###begin title 44
Methylation inhibits constitutive activity of the Nap.
###end title 44
###begin p 45
###xml 523 531 523 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 538 543 538 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M.Sss</italic>
(A) Reporter constructs containing no promoter (pGL3-basic), the R promoter (Rp-LUC) or the Na promoter (Nap-LUC) driving luciferase were transfected into HONE-1, HaCaT or DG75 cells. The luciferase activity produced by each vector is shown (relative to the luciferase activity of the promoterless vector, set as 1). HeLa (B) and DG75 (C) cells were transfected with reporter constructs containing no promoter (none) or the Na promoter (Nap) driving luciferase. Luciferase vectors were either mock-methylated or methylated in vitro using M.Sss1 prior to transfection as indicted. The decrease in luciferase activity derived from the methylated versus unmethylated promoter constructs is indicated (activity of the unmethylated constructs is set at 100%).
###end p 45
###begin p 46
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M.Sss</italic>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hpa</italic>
###xml 462 469 462 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g002">Fig. 2B</xref>
###xml 487 494 487 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g002">Fig. 2C</xref>
To examine the effect of Nap methylation on its activation by cellular factors, we methylated or mock-methylated the Nap-LUC vector, or the promoterless luciferase vector (pGL3-basic), with M.SssI prior to transfection. Digestion of the reporter constructs by HpaII was used to verify their methylation status (data not shown). The constitutive activity of the methylated Nap-LUC vector was much lower than that of the unmethylated construct in both HeLa cells (Fig. 2B) and DG75 cells (Fig. 2C). The low level activity of the promoterless control vector (presumably driven by cryptic binding sites for cellular transcription factors) was likewise decreased by methylation. These results indicate that methylation of the Nap inhibits the ability of cellular transcription factors to activate this promoter.
###end p 46
###begin title 47
Methylation of the Nap is required for efficient Z activation
###end title 47
###begin p 48
###xml 625 632 625 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g003">Fig. 3A</xref>
###xml 704 711 704 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g003">Fig. 3B</xref>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende2">[34]</xref>
###xml 814 821 814 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g003">Fig. 3A</xref>
###xml 980 987 980 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g003">Fig. 3A</xref>
###xml 1191 1195 1191 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Kumar1">[43]</xref>
###xml 1247 1261 1247 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g003">Fig. 3A and 3B</xref>
###xml 672 675 <span type="species:ncbi:10376">EBV</span>
To examine how methylation of the Nap affects its ability to be activated by Z, we transfected HeLa cells with methylated or mock-methylated forms of the Nap-LUC vector in the presence or absence of a Z expression vector. We also examined the effect of methylation on Z activation of Rp-LUC, BHLF1p-LUC (a luciferase vector driven by the early viral BHLF1 promoter, in which the known ZREs cannot be methylated), or the promoterless control luciferase vector (pGL3-basic). Z clearly activated the methylated form of Nap-LUC much more efficiently than the unmethylated form (140-fold activation versus 13-fold) in HeLa cells (Fig. 3A). Similar results were obtained in the EBV-negative B cell line, DG75 (Fig. 3B). As previously described [34], methylation of the Rp also enhanced its ability to be activated by Z (Fig. 3A). In contrast to its effects on the Rp and Nap, methylation of the BHLF1p (which contains CpG-free ZREs) strongly inhibited its ability to be activated by Z (Fig. 3A). Z also induced detectable activation of the promoterless luciferase vector in HeLa and DG75 cells (perhaps reflecting the presence of a previously described cryptic AP1 motif in the luciferase vector) [43], and this activation was inhibited by methylation (Fig. 3A and 3B). These results indicate that both the Nap and Rp are preferentially activated by Z in the methylated form, consistent with the presence of methylation-dependent ZREs in their promoters.
###end p 48
###begin title 49
Methylation of the Nap promotes Z activation.
###end title 49
###begin p 50
###xml 286 294 286 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M.Sss</italic>
###xml 142 145 <span type="species:ncbi:10376">EBV</span>
HeLa (A) and DG75 (B) cells were transfected with a promoterless luciferase vector, or luciferase vectors driven by the Na, R, or BHLF1 lytic EBV promoters, in the presence or absence of a co-transfected Z expression vector. Luciferase vectors were either mock-methylated or methylated in vitro using M.Sss1 prior to transfection as indicted and the amount of luciferase activity determined 48 hours after transfection. The fold-increase in promoter activity in the presence of co-transfected Z (versus a vector control) is shown (obtained from duplicate transfections).
###end p 50
###begin title 51
The Nap has two CpG-containing ZREs that are only bound by Z in the methylated form
###end title 51
###begin p 52
###xml 543 550 543 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g004">Fig. 4A</xref>
###xml 715 722 715 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g004">Fig. 4A</xref>
To map the precise location(s) of the ZREs in the Nap, we synthesized oligonucleotide probes spanning each of the various CpG motifs located within the Nap sequences between -128 and +77, as well as potential predicted ZREs without CpG motifs, and examined the ability of Z to bind to these probes in the methylated or unmethylated forms. We identified two CpG-containing ZREs, located between -53 to -47 ("Nap ZRE1") and -81 to -75 ("Nap ZRE2"). Surprisingly, neither of these Nap ZRE sites is detectably bound by Z in the unmethylated form (Fig. 4A). In contrast, the CpG-containing ZRE sites in the Rp bind to Z in both the methylated and unmethylated forms, albeit more much efficiently in the methylated form (Fig. 4A). Thus, Z binding to the CpG-containing ZREs in the Nap is even more methylation-dependent than Z binding to the CpG-containing ZREs in the Rp. We did not identify any strong Z binding sites using a series of oligonucleotide probes containing potential unmethylated ZREs in the Nap (data not shown).
###end p 52
###begin title 53
Z preferentially binds to the methylated forms of ZRE sites in the Nap.
###end title 53
###begin p 54
###xml 19 27 19 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 292 301 292 301 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T CGC CCG</underline>
###xml 283 312 283 312 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAT TC<underline>T CGC CCG</underline> TGG GCC-3&#8242;</named-content>
###xml 346 355 346 355 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T GAG CGT</underline>
###xml 341 365 341 365 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GT<underline>T GAG CGT</underline> GGC CA-3&#8242;</named-content>
###xml 676 684 676 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
(A) The ability of in vitro translated Z to bind to labeled oligonucleotide probes containing potential ZRE sites in the Nap was examined by EMSA using methylated or mock-methylated probes as indicated. Nap sequences (with probable ZRE sites underlined) were (Nap ZRE1, -58 to -41): 5'-CAT TCT CGC CCG TGG GCC-3' and (Nap ZRE2, -83 to -70): 5'-GTT GAG CGT GGC CA-3'. Binding to the unmethylated and methylated forms of two CpG-containing ZREs in the BRLF1 promoter (Rp) was also examined. The relative efficiency of Z binding to each probe is indicated; the amount of Z binding to the methylated Rp ZRE3 probe is arbitrarily set as 100%. ND: none detected. (B) The ability of in vitro translated Z to bind to the labeled oligonucleotide Nap ZRE1 probe (-58 to -41) containing no methylated cytosine, one methylated cytosine, or two methylated cytosines was compared. The methylated cytosine(s) present in each probe are indicated by a bold C in the sequence.
###end p 54
###begin p 55
###xml 20 21 20 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 24 25 24 25 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 19 26 19 26 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">T<bold>C</bold>GCC<bold>C</bold>G</named-content>
###xml 273 280 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g004">Fig. 4B</xref>
The Nap ZRE1 site (TCGCCCG) contains two CpG motifs. To determine if Z binding to the Nap ZRE1 motif requires methylation of one, or both, cytosines, we synthesized probes that contained one methylated cytosine at either CpG motif, or had both CpGs methylated. As shown in Fig. 4B, Z only binds to the Nap ZRE1 site when both cytosines are methylated. Thus, methylated cytosines at positions -2 and +2 are both essential for Z binding to the methylated Nap ZRE1 site.
###end p 55
###begin p 56
###xml 20 21 20 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 19 26 19 26 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">A<bold>C</bold>GCTCA</named-content>
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 60 67 60 67 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">T<bold>C</bold>GCTCA</named-content>
###xml 360 367 360 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g004">Fig. 4A</xref>
###xml 550 551 550 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 554 555 554 555 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 549 556 549 556 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">T<bold>C</bold>GCC<bold>C</bold>G</named-content>
The Nap ZRE2 site (ACGCTCA) is similar to the Rp ZRE2 site (TCGCTCA). Although the Rp ZRE2 site and the Nap ZRE2 site differ only at position -3 (which is a thymine in the Rp site versus an adenine in the Nap site), Z binds to both the unmethylated and methylated forms of the Rp ZRE2 site, whereas it only binds to the methylated form of the Nap (ZRE2 site) (Fig. 4A). Thus, this one basepair alteration in the ZRE is sufficient to convert the ZRE to completely methylation-dependent Z binding. In contrast to the Nap ZRE2 site, the Nap ZRE1 site (TCGCCCG) is quite different from all previously reported ZREs and is unique in containing methylated cytosines located at both positions -2 and +2.
###end p 56
###begin title 57
Nap ZRE1 and ZRE2 are both required for Z activation of methylated Nap
###end title 57
###begin p 58
###xml 218 225 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g005">Fig. 5A</xref>
###xml 319 326 319 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g005">Fig. 5B</xref>
###xml 413 420 413 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Quinlivan1">[44]</xref>
###xml 636 640 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Carey1">[45]</xref>
To determine if both the Nap ZRE1 and ZRE2 sites are important for Z activation of the methylated Nap-LUC vector, we constructed site-directed mutants of the Nap-LUC that altered the ZRE1 and/or ZRE2 sites as shown in Fig. 5A. Z activation of methylated Nap-LUC was strongly reduced by mutation of either ZRE1 or ZRE2 (Fig. 5B). These results indicate that the ability of Z to activate the methylated form of Nap in vivo to a high level requires the presence of two different CpG-containing ZRE sites. Efficient Z activation of other early lytic viral promoters, such as BMRF1, has likewise been shown to require at least two ZREs [44],[45].
###end p 58
###begin title 59
Nap ZRE1 and ZRE2 are required for Z activation of the methylated Nap.
###end title 59
###begin p 60
(A) site-directed mutations of the two ZREs in Nap-LUC were constructed as indicated. Specific base pairs altered are underlined. (B) HeLa cells were transfected with the methylated Nap-LUC constructs (wildtype versus mutant) in combination with either the empty vector (vector) or the Z expression vector (Z). The amount of luciferase activity determined 48 hours after transfection is shown (obtained from duplicate transfections).
###end p 60
###begin title 61
Serine residue 186, but not cysteine residue 189, is required for Z binding to methylated Nap ZREs
###end title 61
###begin p 62
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Karlsson1">[46]</xref>
###xml 531 539 531 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMRF1</italic>
###xml 1122 1129 1122 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g006">Fig. 6A</xref>
###xml 1326 1333 1326 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g006">Fig. 6A</xref>
A Z mutant in which the Ser186 residue in the basic DNA binding domain is converted to an alanine (the equivalent residue in c-jun and c-fos) binds poorly to the methylated forms of Rp ZRE2 and Rp ZRE3, but binds at least as well as wild-type Z to the consensus AP1 site [22]. More recently, converting Z residue Cys189 to a serine residue was reported to inhibit Z binding to methylated Rp ZRE3, but not AP1 [46]. To determine whether Z residue 186 or 189 regulates Z binding to methylated ZREs in Nap, we compared the ability of in vitro-translated wild-type Z, Z(S186A) and Z(C189S) to bind to labeled oligonucleotide probes containing the Nap ZRE1 and ZRE2 sites, the consensus AP1 site from the BMRF1 early viral promoter, or the Rp ZRE2 and ZRE3 sites. The probes were synthesized such that they contained methylated cytosines at the CpG motifs. The Z(S186A) mutant was highly impaired in comparison to wild-type Z for binding to the methylated forms of the Nap ZRE1 and ZRE2 sites, as well as the Rp ZRE2 and ZRE3 sites, but, as expected, was able to bind to the consensus AP1 site at least as well as wild-type Z (Fig. 6A). The Z(C189S) mutant was slightly impaired for binding to the methylated forms of the Rp ZRE2 and Nap ZRE2 sites, but highly impaired for binding to the methylated forms of Nap ZRE1 and Rp ZRE3 (Fig. 6A). These results indicate that residue Ser186 is absolutely required for Z binding to three of the four known methylation-dependent ZREs (Rp ZRE3, Nap ZRE1 and Nap ZRE2), and greatly enhances Z binding to the other methylated ZRE (Rp ZRE2). In contrast, the requirement for Cys189 varies between the different methylation-dependent ZREs.
###end p 62
###begin title 63
Serine residue 186 is required for Z binding to the ZREs in the Nap.
###end title 63
###begin p 64
###xml 166 174 166 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
(A) EMSA was performed using either methylated or mock-methylated oligonucleotide probes containing the Nap ZRE1, Nap ZRE2, Rp ZRE2, Rp ZRE3 and BMRF1p AP1 sites and in vitro translated wild-type Z (WTZ), ZS186A or ZC189S. The relative efficiency of WTZ, versus mutant Z, binding to each probe is indicated; the amount of WTZ binding to each probe is arbitrarily set as 100%. ND: none detected. (B) The amount of Z protein used in the EMSAs in (a) was quantitated by immunoblot for WT and mutant proteins.
###end p 64
###begin title 65
Serine residue 186 is required for activation of the methylated Nap
###end title 65
###begin p 66
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 537 543 537 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g007">Fig. 7</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende2">[34]</xref>
###xml 754 761 754 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Adamson2">[36]</xref>
###xml 908 912 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Francis1">[37]</xref>
To determine whether Z residue Ser186 is required for activation of the methylated Nap in vivo, we compared the ability of wild-type Z, versus the Z(S186A) mutant, to activate the methylated Nap-LUC construct. The methylated forms of the Nap-LUC or Rp-LUC vectors were co-transfected into HeLa cells with a control vector or vectors expressing either wild-type Z or Z(S186A). Consistent with its inability to bind to methylated Nap ZRE1 and ZRE2 in the EMSAs, Z(S186A) was impaired in the ability to activate the methylated form of Nap (Fig. 7). As previously reported [22],[34], Z(S186A) was also defective in activating the methylated form of Rp. These results indicate that Z Ser186 is important for activating the methylated forms of both Rp and Nap in vivo. Thus, the previously reported finding that the Z(S186A) mutant is unable to disrupt viral latency in the context of the intact viral genome [36],[37] may reflect not only its inability to activate the Rp, but also its inability to activate the Nap.
###end p 66
###begin title 67
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Serine residue 186 is required for Z activation of the methylated Nap in vivo.
###end title 67
###begin p 68
HeLa cells were transfected with methylated luciferase vectors driven by the Na or R promoters, in the presence or absence of a co-transfected wild-type Z (WTZ), or the Z(S186A) mutant altered in the DNA binding domain at residue 186. The amount of luciferase activity produced by each condition (obtained from duplicate transfections) is indicated.
###end p 68
###begin title 69
The Nap is highly methylated in latently infected cells
###end title 69
###begin p 70
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
###xml 891 898 891 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000356-t001">Table 1</xref>
###xml 123 126 <span type="species:ncbi:10376">EBV</span>
###xml 319 322 <span type="species:ncbi:10376">EBV</span>
###xml 362 365 <span type="species:ncbi:10376">EBV</span>
###xml 430 433 <span type="species:ncbi:10376">EBV</span>
###xml 476 479 <span type="species:ncbi:10376">EBV</span>
Although the Rp was previously shown by our laboratory to be highly methylated in a variety of different latently infected EBV-positive cell lines [22], the methylation status of the Nap has not been previously reported. To examine this, we isolated DNA from a) 293 cells infected with a BZLF1-deleted virus, b) HONE-1/EBV cells (an NPC line super-infected with EBV), c) SNU-719 cells (a gastric carcinoma line which has remained EBV-positive in culture) or d) Raji cells (an EBV-positive Burkitt lymphoma line), and then treated the DNA with sodium bisulfite, converting unmethylated, but not methylated, cytosine residues into thymine residues. Following bisulfite treatment, the Nap sequence was PCR-amplified and cloned into the pT7Blue vector (Novagen). A number of different clones derived from each cell line were sequenced to determine the methylation status of the Nap. As shown in Table 1, the ZREs in the Nap were both highly methylated in each cell line. These results suggest that the ability of Z to bind to the methylated forms of the two ZREs in Nap is likely essential for its ability to activate Na transcription in latently infected cells.
###end p 70
###begin title 71
###xml 35 38 <span type="species:ncbi:10376">EBV</span>
Methylation of the Nap ZREs in the EBV genome.
###end title 71
###begin p 72
###xml 123 126 <span type="species:ncbi:10376">EBV</span>
The cytosine methylation status of the CpG motifs within the ZRE1 and ZRE2 sites in the Nap in different latently infected EBV+ cell lines is shown. The number of clones found to contain a methylated CpG in each Nap ZRE, versus the number of clones sequenced in each cell line (following bisulfate treatment), is indicated.
###end p 72
###begin title 73
Wild-type Z but not Z(S186A) activates Na and R expression in latently infected 293 cells
###end title 73
###begin p 74
###xml 506 509 506 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Israel1">[8]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Adamson2">[36]</xref>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Francis1">[37]</xref>
###xml 668 674 668 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g008">Fig. 8</xref>
###xml 1144 1149 1144 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 369 372 <span type="species:ncbi:10376">EBV</span>
To determine if Z binding to the methylated form of the Nap is required for Z activation of Na expression in the context of the intact viral genome, we compared the ability of wild-type Z, the Z(S186A) mutant, or the Z(C189S) mutant to activate Na expression in the presence or absence of an R expression vector in 293 cells stably infected with a BZLF1-deleted mutant EBV. In the context of the intact latent viral genome, both Z and R are required to induce expression of most early lytic gene promoters [8]. As previously reported [36],[37], the Z(S186A) mutant by itself was not able to induce expression of the R protein, or the early viral protein EA-D (BMRF1) (Fig. 8). This defect was observed even when the Z(186A) mutant was expressed at extremely high levels (data not shown). However, in combination with an R expression vector, Z(S186A) activated EA-D, consistent with the known ability of this mutant to bind to the BMRF1 promoter ZREs. Furthermore, in comparison to wild-type Z, the Z(S186A) mutant was also impaired for the ability to activate expression of Na, and this defect persisted even when the R protein was supplied in trans. The Z(C189S) mutant was similar to wild-type Z in its ability to activate R, EA-D and Na expression, consistent with its ability to bind (at least weakly) to one or more ZREs in each promoter. These results confirm that the ability of Z to bind to the methylated form of the Nap is required for efficient Z activation of Na expression in the context of the intact viral genome in latently infected cells.
###end p 74
###begin title 75
Wild-type Z, but not Z(S186A), activates Na and R transcription.
###end title 75
###begin p 76
Wild-type Z (WTZ), Z(S186A), Z(C189S) or empty vector (vector) were transfected in to 293 Z-KO cells in the presence or absence of an R expression vector and assayed by western blot for expression of Z, R, Na, EA-D or beta-actin.
###end p 76
###begin title 77
Modeling Z interactions with methylated and unmethylated ZREs
###end title 77
###begin p 78
###xml 209 215 209 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g009">Fig. 9</xref>
The sequences of the consensus AP1 site (from the BMRF1p), a ZRE which is bound by Z in the unmethylated form (from the Rp), and the four known methylation-sensitive ZREs (from the Rp and Nap) are compared in Fig. 9. Interestingly, the ZREs which are bound by Z in the methylated form all have a CpG motif in the left half-site at the same position (leading to methylated cytosines at -2 and +1').
###end p 78
###begin title 79
Comparison of ZRE sites.
###end title 79
###begin p 80
Sequences of the consensus AP1 site, the three Rp ZRE sites and the two Nap ZREs are shown. Methylated cytosines are indicated with an asterisk.
###end p 80
###begin p 81
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Petosa1">[35]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Karlsson1">[46]</xref>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10A</xref>
###xml 514 522 514 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10A</xref>
###xml 666 672 666 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g009">Fig. 9</xref>
To explore why methylation of some ZRE sites is required for Z binding, we used the Sybyl program to model the interaction of Z with the newly discovered methylated Nap ZREs versus the AP1 site. Consistent with previous observations modeling the binding of Z to methylated ZREs in the Rp [35],[46], our model of Z binding to the methylated Nap ZRE2 left-half site (Fig. 10A, upper panel) indicates that the cytosine methyl group at +1' occupies the same position as the thymine methyl group (+1') in the AP1 site (Fig. 10A, lower panel). Interestingly, this cytosine is present in the same location within the left half-sites of all four methylation-sensitive ZREs (Fig. 9).
###end p 81
###begin title 82
Modeling of Z binding to methylated ZRE sites versus AP1.
###end title 82
###begin p 83
(A) The predicted structure and hydrogen interactions between WT Z bound to Nap ZRE2 (upper panel, stereoview) is compared to Z(S186A) bound to the AP1 site (lower panel, stereoview). Z is shown as a green ribbon; hydrogen interactions are indicated by dotted black lines and the two DNA strands are shown as orange and cyan tubes. The left half-sites of Nap ZRE2 and AP1 are shown in cyan basepair stick as indicated. (B) Stereoview illustration of Z binding to the right half-site of methylated Nap ZRE1 is shown. A purple ball-and-stick model highlights the key difference of the Z/AP1 structure (at position -3' thymine and +3 adenine) compared to the Z/Nap ZRE1 structure, as well as the different sidechain conformations of Asn182'. (C) Z Cys189 forms van der Waals contacts with the -2' thymine unique to Rp ZRE3. Van der Waals contacts between the -2' thymine position unique to the Rp ZRE3 DNA molecule and Cys189 are highlighted (yellow contour). This interaction is greatly reduced with a guanine present at the -2' position (purple contour). Additionally, mutation of Cys189 to a serine residue greatly reduces the van der Waals interaction (red contour) with the -2' Rp ZRE3 thymine.
###end p 83
###begin p 84
###xml 652 658 652 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g009">Fig. 9</xref>
###xml 765 773 765 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10A</xref>
###xml 889 895 889 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g009">Fig. 9</xref>
We also observed that methylation of cytosines in the Nap ZRE2 site helps to define the sidechain conformation of the Z Ser186 and Asn182 residues, and stabilize a hydrogen bonding network. Upon methylation, the two cytosine methyl groups (+1' and -2) limit the sidechain movement of Ser186, stabilizing its hydrogen bonds to the amine groups of both cytosines (+1' and -2) and to the carbonyl group of Asn182. This helps define the sidechain of Asn182 to a different conformation which allows it to form hydrogen bonds with several DNA bases, including the guanine at +2' which is present in the left half-site of all four methylation-sensitive ZREs (Fig. 9). In addition, this conformation of Asn182 stabilizes a hydrogen bond with the adenine at -3 in Nap ZRE2 (Fig. 10A). The adenine at -3, which is occupied by a thymine in the other methylated and unmethylated ZREs, as well as AP1 (Fig. 9), is unique to the Nap ZRE2 site. Thus, the hydrogen bonds in this network appear to be most abundant with the Z/Nap ZRE2 complex, helping to explain why the Nap ZRE2 interaction with Z absolutely relies on methylation. In addition, this architecture explains why mutation of Ser186 to alanine, which would attenuate this hydrogen bonding network, greatly abrogates Z binding to methylated Nap ZRE2.
###end p 84
###begin p 85
###xml 152 160 152 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10B</xref>
###xml 311 319 311 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10B</xref>
A model of Z bound to the right half-site of the methylated Nap ZRE1 site, which has a unique CpG not present in the other methylated ZREs, is shown in Fig. 10B. Similar to position +1', the methylated cytosine at position -3' of Nap ZRE1 mimics the thymine present at -3' in AP1 and all other methylated ZREs (Fig. 10B). Our model demonstrates that methylation of the cytosines in the right half-site of Nap ZRE1 helps to stabilize the sidechain of Asn182' to a different conformation, allowing it to form hydrogen bonds with the altered nucleotides at -3' and +3. Methylation of the cytosine at -3' also defines the sidechain conformation of Ser186' and Arg190', and stabilizes the hydrogen bonds between Ser186' and Arg190', and between Arg190' and two phosphate groups of DNA backbone.
###end p 85
###begin p 86
###xml 72 78 72 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g009">Fig. 9</xref>
###xml 146 154 146 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10C</xref>
###xml 269 277 269 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10C</xref>
###xml 336 344 336 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10C</xref>
Interestingly, the Rp ZRE3 right half-site has a unique thymine at -2' (Fig. 9), which leads to van der Waals contacts of this thymine to Cys189 (Fig. 10C, yellow contour). This interaction is absent in other ZREs and AP1, which have a common guanine at this position (Fig. 10C, purple contour). Mutation of Cys189 to a serine residue (Fig. 10C, red contour) is predicted to greatly reduce the van der Waals contact to the -2' thymine of Rp ZRE3. Collectively, this explains why Cys189 is most important for Z binding to Rp ZRE3.
###end p 86
###begin title 87
Discussion
###end title 87
###begin p 88
###xml 848 855 848 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 4 7 <span type="species:ncbi:10376">EBV</span>
###xml 231 234 <span type="species:ncbi:10376">EBV</span>
###xml 677 680 <span type="species:ncbi:10376">EBV</span>
###xml 961 964 <span type="species:ncbi:10376">EBV</span>
###xml 1195 1198 <span type="species:ncbi:10376">EBV</span>
The EBV Z protein, which mediates the switch from latent to lytic viral infection, is to date the only transcription factor shown to preferentially bind to, and activate, the methylated form of a target promoter. However, only one EBV promoter (Rp) has previously been shown to be preferentially bound, and activated, by Z in the methylated form. Indeed, all other previously identified Z binding sites in early lytic promoters do not even contain CpG motifs. Thus, whether methylated CpG-containing ZRE sites are specifically important for Z activation of the Rp, but not other viral promoters, has remained unclear. In this report, we identify two CpG-containing ZREs in the EBV early lytic Nap, and show that these ZREs are only bound by Z in the methylated state. Furthermore, we demonstrate that the Nap can only be activated by Z efficiently in vivo when the promoter is methylated. In addition, we show that both Nap ZREs are generally methylated in the EBV genome of latently infected cells. Our molecular modeling studies of Z bound to these new Nap ZREs help to explain why methylation of these sites is required for Z binding. Together, these results indicate that methylation of the EBV genome not only enhances Z activation of R transcription, but is required for Z activation of Na transcription. This apparently unique feature of Z likely helps the virus to efficiently activate lytic viral gene transcription when the viral genome is highly methylated. Conversely, the inability of Z to induce expression of the viral transcription factors, R and Na, from the incoming (unmethylated) viral genome may help the virus to establish latency.
###end p 88
###begin p 89
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRLF1</italic>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende2">[34]</xref>
###xml 414 421 414 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g004">Fig. 4A</xref>
###xml 786 793 786 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g003">Fig. 3A</xref>
###xml 93 96 <span type="species:ncbi:10376">EBV</span>
Our laboratory previously showed that Z preferentially binds to and activates the methylated EBV BRLF1 gene promoter, Rp, through two CpG-containing ZREs. Z does not bind to all methylated CpG motifs, but rather binds to methylated CpGs embedded within ZRE-like motifs [22],[34]. In the case of the Rp, we found that Z binds to both the unmethylated, as well as methylated, forms of the Rp ZRE2 and Rp ZRE3 sites (Fig. 4A) (although binding to the methylated form is much more efficient, particularly in the case of the Rp ZRE3). The Rp also has one ZRE (Rp ZRE1) which does not contain a CpG and therefore cannot be methylated. Of note, while Z activates the methylated form of the Rp more efficiently than the unmethylated form, it clearly also activates the unmethylated form of Rp (Fig. 3A). The ability of Z to activate unmethylated Rp is likely mediated by binding to the unmethylated Rp ZRE1 and ZRE2 sites.
###end p 89
###begin p 90
###xml 173 174 173 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 177 178 177 178 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 172 179 172 179 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">T<bold>C</bold>GCC<bold>C</bold>G</named-content>
###xml 315 323 315 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 447 454 447 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In the case of the Nap, both of the ZREs identified contain CpG motifs, and require methylation for Z binding. Furthermore, Z binding to the highly atypical Nap ZRE1 site (TCGCCCG), which contains two CpG motifs, requires methylation of both CpGs. Consistent with this methylation-dependent binding of Z to the Nap in vitro, we found that methylation of the Nap is required for efficient Z activation of a Nap driven luciferase reporter construct in vivo. In fact, Z activation of the Nap may be even more dependent upon promoter DNA methylation than Z activation of Rp. Site-directed mutation of either ZRE in the Nap greatly abrogated Z activation of the methylated Nap-luciferase construct, indicating that the presence of both ZREs is important for Z activation. While Nap methylation is required for Z activation, we found that it has the opposite effect on the ability of cellular transcription factors to activate the Nap. Thus, although the Nap has high constitutive activity in the unmethylated form, it is completely inactive in the methylated form unless Z is present.
###end p 90
###begin p 91
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-SegouffinCariou1">[18]</xref>
###xml 202 210 202 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-SegouffinCariou1">[18]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Flemington3">[47]</xref>
Although a previous report suggested that bacterially produced His-tagged Z protein can bind to the unmethylated form of Nap [18], we found only weak Z binding to the unmethylated form of the Nap using in vitro translated Z as a source of protein in EMSAs. Therefore, a post-translational modification of Z that does not occur in bacterial cells, or an interaction with another cellular protein(s), may be required to observe methylation-dependent Z binding to the Nap ZREs. Z was also reported to activate the unmethylated form of Nap in a reporter gene assay [18]. We speculate that this previous result may reflect the ability of Z to activate certain reporter gene constructs through a non-DNA binding mechanism when expressed at very high levels and/or the presence of cryptic AP1 sites in some reporter gene vectors [47]. To date, Z activation of lytic viral genes in the context of the intact viral genome requires direct Z binding to the viral promoters. Cellular factors could potentially stabilize weak Z binding to the unmethylated form of Nap in some cell types.
###end p 91
###begin p 92
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
###xml 495 499 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Adamson2">[36]</xref>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Francis1">[37]</xref>
###xml 790 797 790 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1011 1016 1011 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRLF1</italic>
###xml 1051 1056 1051 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRRF1</italic>
###xml 647 650 <span type="species:ncbi:10376">EBV</span>
We and others have previously shown that a Z(S186A) mutant binds very poorly to the methylated forms of Rp ZRE2 and Rp ZRE3, even though this alteration does not affect Z binding to the consensus (and unmethylated) AP1 motif [22]. Furthermore, the Z(S186A) mutant cannot disrupt viral latency when transfected into latently infected cells, and this phenotype is at least partially reversed when the R protein is supplied in trans, expressed under the control of a constitutively active promoter [36],[37]. In this paper, we have shown that the Z mutant, Z(S186A), is severely impaired for binding to each of the four known methylated ZRE sites in EBV. Consistent with its methylation-dependent binding defect, the Z(S186A) mutant is unable to activate the methylated Nap reporter construct in vivo, or to induce Na expression from the methylated viral genome in latently infected cells even in the presence of a co-transfected R expression vector. The finding that the Z(S186A) mutant is defective not only for BRLF1 (R) gene activation, but also for BRRF1 (Na) gene activation, suggests that loss of both R and Na protein expression may contribute to its phenotype.
###end p 92
###begin p 93
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Petosa1">[35]</xref>
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Karlsson1">[46]</xref>
###xml 649 657 649 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10A</xref>
###xml 930 938 930 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10A</xref>
###xml 970 978 970 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10A</xref>
###xml 1749 1757 1749 1757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10B</xref>
###xml 1911 1919 1911 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10B</xref>
###xml 1505 1508 <span type="species:ncbi:10376">EBV</span>
Although the crystal structure of Z bound to the consensus AP1 site has been published [35], the crystal structure of Z bound to a methylated ZRE site has not yet been reported. Karlsson et al. recently suggested that Z residue Ser186 stabilizes Z binding to the left half-sites of methylated Rp ZRE2 and Rp ZRE3 by directly interacting with the methyl group of the cytosine located at position +1', and thereby stabilizing a hydrogen bonding network involving Ser186, Asn182 and the guanine located at +2' [46]. Our models agree with this notion except that more hydrogen bonds were identified in this network, particularly in Z bound to Nap ZRE2 (Fig. 10A, upper panel). The difference in the hydrogen bond network of Z/Nap ZRE2 appears to be contributed by its unique adenine at the -3 position. Its hydrogen bond to Asn182 requires that the carbonyl and the amine groups of the Asn182 sidechain are in the opposite direction (Fig. 10A, upper panel) compared to AP1 (Fig. 10A, lower panel). We hypothesize that stabilization of this conformation in Nap ZRE2 relies more on this methylated CpG motif than in Rp ZRE2, which differs from Nap ZRE2 only at the -3 position. This is consistent with our observation that unmethylated Nap ZRE2 fails to bind Z while unmethylated Rp ZRE2 can still bind. In all of our models, Ser186 appears to play a central role in bridging the hydrogen bond networks, consistent with the observation that Z(S186A) is impaired for binding to all four known methylated ZREs in EBV. In addition to the left half-site, Ser186' clearly plays a role in forming a second hydrogen bond network, interacting with the unique CpG motif on the right half-site of Nap ZRE1; this network also relies on methylation of the CpG motif (Fig. 10B). The sidechain conformation of Asn182' likewise changes in context of the altered sequence of the Nap ZRE1 right half-site for hydrogen bond formation (Fig. 10B). Thus, the ability of Z to recognize different ZREs partially relies on stabilization of Asn182 conformations for formation of hydrogen bonds that vary depending on the context of different DNA sequences.
###end p 93
###begin p 94
###xml 222 230 222 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10A</xref>
###xml 464 472 464 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10B</xref>
Consistent with previous observations, the common CpG motif at the left half-site gives rise to a methylated cytosine at the +1' position in all four methylation-sensitive ZREs that mimics the structure of thymine in AP1 (Fig. 10A). Interestingly, the unique CpG motif at the right half-site of Nap ZRE1 also gives rise to a methylated cytosine at the -3' position that mimics the structure of the common -3' thymine present in most other ZREs, as well as in AP1 (Fig. 10B). This observation suggests that the ability of methylated cytosines to mimic thymine in DNA-protein interactions might be a more common phenomenon.
###end p 94
###begin p 95
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Schelcher1">[48]</xref>
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Wang1">[49]</xref>
###xml 459 463 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Wang1">[49]</xref>
###xml 474 480 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 732 736 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Karlsson1">[46]</xref>
###xml 1157 1161 1153 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Karlsson1">[46]</xref>
###xml 1307 1315 1303 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000356-g010">Fig. 10C</xref>
###xml 1602 1606 1598 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Karlsson1">[46]</xref>
###xml 1821 1825 1817 1821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende1">[22]</xref>
Another factor regulating the binding of Z to DNA is the redox state of the bZIP domain [48],[49]. This regulation is conserved in many of the bZIP proteins, including c-fos and c-jun. In contrast, DNA binding of C/EBPalpha, which contains a serine residue in the place of the usual cysteine residue, is insensitive to the redox environment. Z possesses the bZIP protein conserved cysteine at residue 189, and the DNA-binding function of Z is redox dependent [49]. Karlsson et al. recently reported that Z(C189S) is defective in binding to the methylated Rp ZRE3 site (although this defect was not redox dependent), and based on this finding proposed that Z Cys189 directly contributes to Z binding to at least some methylated ZREs [46]. In our experiments, we confirmed that Z(C189S) is highly impaired for binding to the methylated form of the Rp ZRE3 site, as well as the Nap ZRE1 site, but much less impaired for binding to the methylated forms of Nap ZRE2 and Rp ZRE2. These results suggest that Z Cys189, in contrast to Z Ser186, is required for binding to a limited subset of methylated ZREs. Consistent with the previous model of Z bound to Rp ZRE3 [46], our model likewise predicts that van der Waals contacts occur between the -2' thymine position unique to the Rp ZRE3 DNA molecule and Z Cys189 (Fig. 10C). However, the Z(C189S) mutant is not predicted to have these interactions. Our finding that Z(C189S) binds to some methylation-dependent ZREs more efficiently than to the Rp ZRE3 site may reflect the absence of a thymine at the -2' position in these other ZREs. As previously reported [46], we found that the Z(C189S) mutant induces lytic infection in latently infected 293 cells almost as well as wild-type Z, perhaps reflecting our previous finding that some Rp ZREs are unmethylated in this cell type [22].
###end p 95
###begin p 96
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Hong1">[19]</xref>
###xml 54 57 <span type="species:ncbi:10376">EBV</span>
###xml 642 645 <span type="species:ncbi:10376">EBV</span>
###xml 769 772 <span type="species:ncbi:10376">EBV</span>
The fact that the Rp and Nap are potentially the only EBV promoters which are preferentially bound, and activated, by Z in the methylated form suggests that these two promoters may be activated in tandem. Since our laboratory has previously shown that Na cooperates with R to activate the Z promoter in the context of the intact viral genome [19], the ability of the Z protein to activate both R and Na transcription efficiently from the methylated form of the viral genome may serve as an essential positive autoregulatory loop in the initial stage of viral reactivation. However, since the EMSA assays performed to search for ZREs in lytic EBV promoters have not generally used methylated DNA probes, many undiscovered methylation-dependent ZREs may yet exist in the EBV genome. Whether there are also methylation-dependent ZREs in the cellular genome remains unknown.
###end p 96
###begin p 97
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Bhende2">[34]</xref>
###xml 1373 1377 1373 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Tsai1">[50]</xref>
###xml 1378 1382 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Tsai2">[51]</xref>
###xml 2144 2148 2144 2148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000356-Adamson3">[52]</xref>
###xml 47 50 <span type="species:ncbi:10376">EBV</span>
###xml 390 393 <span type="species:ncbi:10376">EBV</span>
We previously showed that demethylation of the EBV genome in latently infected 293 cells inhibits the ability of Z to induce lytic viral gene expression [34], strongly suggesting that viral genome methylation promotes the ability of Z to activate lytic genes in the context of the intact viral genome. Based upon the results presented here, we propose the following model to illustrate how EBV uses R and Na promoter methylation to enhance both the latent, and lytic, forms of infection. In cell types (such as oropharyngeal epithelial cells) where viral infection is normally completely lytic, and thus the viral genome does not become methylated, we propose that R and Na, rather than Z, may be the primary mediators of lytic gene expression, since the ability of R and Na to induce Z expression does not require viral genome methylation (and in fact may be inhibited by methylation). During infection of cells (such as B cells) that normally undergo the latent form of infection, the inability of Z to activate R and Na transcription efficiently from the incoming unmethylated viral genome helps the virus to establish latency. Following establishment of viral latency, the viral genome eventually becomes highly methylated (potentially reflecting the ability of the virally encoded latent LMP1 protein to activate expression of the cellular methyltransferase 1 protein [50],[51]). Methylation of the Na and R promoters inhibits their ability to be activated by cellular transcription factors, further promoting viral latency as long as the Z protein is not available. However, following reactivation of Z expression by stimuli such as plasma cell differentiation, methylation of the Na and R promoters enhances Z binding, perhaps ensuring that a limiting amount of Z preferentially binds to ZREs in the R and Na promoters. Alternatively, the conformation of full-length Z bound to methylated ZREs may be subtlety different from its conformation bound to unmethylated ZREs. If so, Z bound to methylated ZREs may interact more strongly with co-activator proteins such as CBP, and thus activate promoters with methylated ZREs more efficiently [52]. In combination, expression of the Z, R and Na proteins is then sufficient to initiate the entire lytic cascade of viral gene expression.
###end p 97
###begin p 98
We thank Paul Lambert and Janet Mertz for reviewing the manuscript, and H.-J. Delecluse for BZLF1-KO 293 cells.
###end p 98
###begin title 99
References
###end title 99
###begin article-title 100
###xml 0 3 <span type="species:ncbi:10376">EBV</span>
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.
###end article-title 100
###begin article-title 101
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus replication in oropharyngeal epithelial cells.
###end article-title 101
###begin article-title 102
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Epstein-Barr virus infection and replication in a human epithelial cell system.
###end article-title 102
###begin article-title 103
###xml 31 49 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 51 54 <span type="species:ncbi:10376">EBV</span>
###xml 89 92 <span type="species:ncbi:10376">EBV</span>
trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.
###end article-title 103
###begin article-title 104
###xml 78 96 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.
###end article-title 104
###begin article-title 105
###xml 0 3 <span type="species:ncbi:10376">EBV</span>
EBV Lytic Infection.
###end article-title 105
###begin article-title 106
Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.
###end article-title 106
###begin article-title 107
Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.
###end article-title 107
###begin article-title 108
###xml 5 23 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 25 28 <span type="species:ncbi:10376">EBV</span>
###xml 120 123 <span type="species:ncbi:10376">EBV</span>
Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.
###end article-title 108
###begin article-title 109
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif.
###end article-title 109
###begin article-title 110
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.
###end article-title 110
###begin article-title 111
###xml 47 65 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues.
###end article-title 111
###begin article-title 112
###xml 18 36 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1.
###end article-title 112
###begin article-title 113
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
###end article-title 113
###begin article-title 114
###xml 60 78 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R.
###end article-title 114
###begin article-title 115
Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.
###end article-title 115
###begin article-title 116
###xml 24 42 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.
###end article-title 116
###begin article-title 117
Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus.
###end article-title 117
###begin article-title 118
###xml 21 47 <span type="species:ncbi:33708">murine gammaherpesvirus 68</span>
The ORF49 protein of murine gammaherpesvirus 68 cooperates with RTA in regulating virus replication.
###end article-title 118
###begin article-title 119
BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.
###end article-title 119
###begin article-title 120
###xml 162 180 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
###end article-title 120
###begin article-title 121
###xml 54 72 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.
###end article-title 121
###begin article-title 122
Methylation-induced repression-belts, braces, and chromatin.
###end article-title 122
###begin article-title 123
Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein.
###end article-title 123
###begin article-title 124
Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene.
###end article-title 124
###begin article-title 125
Sp1 binding is inhibited by (m)Cp(m)CpG methylation.
###end article-title 125
###begin article-title 126
DNA methylation and gene activity.
###end article-title 126
###begin article-title 127
Mammalian methyltransferases and methyl-CpG-binding domains: proteins involved in DNA methylation.
###end article-title 127
###begin article-title 128
CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation.
###end article-title 128
###begin article-title 129
Inactive chromatin spreads from a focus of methylation.
###end article-title 129
###begin article-title 130
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.
###end article-title 130
###begin article-title 131
###xml 4 7 <span type="species:ncbi:10376">EBV</span>
The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome.
###end article-title 131
###begin article-title 132
###xml 50 68 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
###end article-title 132
###begin article-title 133
###xml 14 32 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
###end article-title 133
###begin article-title 134
###xml 148 166 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
###end article-title 134
###begin article-title 135
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.
###end article-title 135
###begin article-title 136
###xml 38 43 <span type="species:ncbi:9606">human</span>
Establishment and characterization of human gastric carcinoma cell lines.
###end article-title 136
###begin article-title 137
###xml 64 69 <span type="species:ncbi:9606">human</span>
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
###end article-title 137
###begin article-title 138
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
###end article-title 138
###begin article-title 139
###xml 40 58 <span type="species:ncbi:10376">Epstein-Barr virus</span>
X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.
###end article-title 139
###begin article-title 140
###xml 14 17 <span type="species:ncbi:10116">rat</span>
Regulation of rat ornithine decarboxylase promoter activity by binding of transcription factor Sp1.
###end article-title 140
###begin article-title 141
###xml 79 97 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
###end article-title 141
###begin article-title 142
###xml 31 49 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.
###end article-title 142
###begin article-title 143
###xml 123 141 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein.
###end article-title 143
###begin article-title 144
###xml 37 55 <span type="species:ncbi:10376">Epstein-Barr virus</span>
DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.
###end article-title 144
###begin article-title 145
###xml 67 85 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 87 90 <span type="species:ncbi:10376">EBV</span>
###xml 156 159 <span type="species:ncbi:10376">EBV</span>
Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency.
###end article-title 145
###begin article-title 146
###xml 50 68 <span type="species:ncbi:10376">Epstein-Barr virus</span>
A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication.
###end article-title 146
###begin article-title 147
###xml 41 44 <span type="species:ncbi:10376">EBV</span>
Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling.
###end article-title 147
###begin article-title 148
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases.
###end article-title 148
###begin article-title 149
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein.
###end article-title 149
###begin p 150
The authors have declared that no competing interests exist.
###end p 150
###begin p 151
This work was supported by National Institutes of Health grants R01 CA058853, 5-P01-CA19014, and 5-P01-CA022443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 151

